NIOX logo

NIOX Group Share Price

Symbol: AIM:NIOXMarket Cap: UK£281.4mCategory: Healthcare

NIOX Share Price Performance

NIOX Community Fair Values

    Recent NIOX News & Updates

    No updates

    NIOX Group Plc Key Details

    UK£41.8m

    Revenue

    UK£11.6m

    Cost of Revenue

    UK£30.2m

    Gross Profit

    UK£26.8m

    Other Expenses

    UK£3.4m

    Earnings

    Last Reported Earnings
    Dec 31, 2024
    Next Reporting Earnings
    Sep 30, 2025
    Earnings per share (EPS)
    0.0081
    Gross Margin
    72.25%
    Net Profit Margin
    8.13%
    Debt/Equity Ratio
    0%

    NIOX Group Plc Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About NIOX

    Founded
    2006
    Employees
    91
    CEO
    Jonathan Emms
    WebsiteView website
    www.niox.com

    NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.

    U.K. Market Performance

    • 7 Days: 1.6%
    • 3 Months: 7.6%
    • 1 Year: 7.9%
    • Year to Date: 8.1%
    Over the last 7 days, the market has risen 1.6%, driven by gains of 5.8% in the Materials sector. In the last year, the market has climbed 7.9%. Looking forward, earnings are forecast to grow by 14% annually. Market details ›
    The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.
    Continue reading